§ Funding Round
Series B funding round for 858 Therapeutics raising $50M in September 2024
Series B funding round for 858 Therapeutics raising $50M in September 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Angel | ali behbahani | |
New Enterprise Associates | — | — |
| Organization | — | |
avidity partnersLEAD | Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$110M
Top Valuation
-
858 Therapeutics raised $50M in a Series B round.
The round was announced on 09/01/24.
The round was led by avidity partners.
